Esaote Launches New CrystaLine at ECR 2014
Enhancing the Productivity, Efficiency and Value of Ultrasound
Realising Application of Ultrasound Through Prevention, Diagnosis to Intervention & Therapy
LONDON--(BUSINESS WIRE)--Esaote, one of the world’s leading manufacturers of medical diagnostic systems, today launches CrystaLine, a significant evolution of its ultrasound technology that delivers new levels of accuracy, quality, versatility and value.
“This feature plus the introduction of the 0 degrees biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”
CrystaLine’s superior technical capabilities enable high quality images to be captured at greater depth in the body. This significant improvement overcomes the challenges associated with larger and difficult to scan patients.
CrystaLine incorporates specific hardware and software features that build on the advanced eHD ultrasound technology Esaote introduced last year. The reality of higher quality, clearer imaging at increased depth, now enables clinicians to confidently use ultrasound in borderline examinations and interventional ultrasound procedures.
Carlos Faustmann, Esaote’s Chief Global Marketing and Domestic Sales Officer, explains: “Ultrasound is highly valued for its safe, non-invasive nature, and continues to evolve and prove its value. One of the challenges has been capturing high quality images in those technically difficult patients. CrystaLine changes all that.”
CrystaLine: A flexible tool for multiple Ultrasound applications
Major technical improvements provided by CrystaLine include Combined Pulse Imaging Technology which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, helps to produce an optimal personalised image.
Esaote systems with CrystaLine are also able to synchronise in real-time with therapeutic applications.
“CrystaLine enables clinicians to synchronise with interventional systems such as medical lasers,” continues Faustmann. “This feature plus the introduction of the 0 degrees biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”
Additional Dedicated MRI and Healthcare IT advances unveiled at ECR
The new eXP Technology upgrade for Esaote’s Dedicated MRI systems enables faster examinations and increased diagnostic confidence. eXP Technology will be showcased on the O-scan and G-scan Brio to demonstrate enhanced image quality.
SUITESTENSA RIS PACS advanced information will also be unveiled at ECR. Suitestensa now includes second-generation Structured Report functionalities and 3D applications. Mobile PACs enables off-site access to images.
Upgrade for existing systems
Esaote MyLabTMTwice, Seven and Alpha systems are showcased with CrystaLine at ECR 2014 together with the eXP Technology on G-scan brio and O-scan. CrystaLine and eXP Technology will be available as an upgrade to existing versions of these.
Exhibiting at ECR 2014: